Algorae Pharmaceuticals Limited
LVCLF
$0.0063
$0.000916.67%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.49M | 1.67M | 2.07M | 2.03M | 2.47M |
| Total Receivables | 30.70K | 34.40K | 28.50K | 27.90K | 47.10K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 49.70K | 55.70K | 27.70K | 27.10K | 45.30K |
| Total Current Assets | 1.57M | 1.76M | 2.13M | 2.08M | 2.56M |
|
|
|||||
| Total Current Assets | 1.57M | 1.76M | 2.13M | 2.08M | 2.56M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | 1.10K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.57M | 1.76M | 2.13M | 2.08M | 2.56M |
|
|
|||||
| Total Accounts Payable | 84.90K | 95.20K | 77.90K | 76.10K | 75.80K |
| Total Accrued Expenses | 5.20K | 5.90K | 41.20K | 40.30K | 19.70K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 90.20K | 101.00K | 119.10K | 116.40K | 95.50K |
|
|
|||||
| Total Current Liabilities | 90.20K | 101.00K | 119.10K | 116.40K | 95.50K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 90.20K | 101.00K | 119.10K | 116.40K | 95.50K |
|
|
|||||
| Common Stock & APIC | 50.46M | 56.54M | 54.40M | 53.17M | 55.58M |
| Retained Earnings | -49.34M | -55.28M | -52.76M | -51.57M | -53.55M |
| Treasury Stock & Other | 362.40K | 406.00K | 371.70K | 363.30K | 443.30K |
| Total Common Equity | 1.48M | 1.66M | 2.01M | 1.97M | 2.47M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.48M | 1.66M | 2.01M | 1.97M | 2.47M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.48M | 1.66M | 2.01M | 1.97M | 2.47M |
|
|
|||||